Why is Aarti Pharma falling/rising?

As of 11-Sep, Aarti Pharmalabs Ltd is experiencing a price increase, currently trading at 910.00, which reflects a rise of 8.95 or 0.99%. The stock has shown strong performance today, outperforming its sector by 0.52%. It is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 19.06% compared to the 5-day average. Over the past week, the stock has gained 1.68%, and over the past month, it has increased by 6.17%, significantly outperforming the Sensex, which has risen by only 1.03% during the same period.
In the broader market context, Aarti Pharmalabs has demonstrated a remarkable ability to generate returns, achieving a 35.31% increase over the past year while the BSE500 index has seen negative returns of -2.29%. The company's strong fundamentals, including a low Debt to EBITDA ratio of 0.63 times and a return on capital employed (ROCE) of 16.1, contribute to its attractive valuation. Furthermore, the stock is trading at a discount compared to its peers' average historical valuations, which supports its upward movement. Overall, the combination of strong financial metrics and positive market performance has led to the stock's rising price.